BOBBIE FERRELL: Open Payments
NPI 1184961419 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,202 in 141 payments from 20 companies in 2025. Trend: 2023 $1,907 · 2024 $2,481 · 2025 $3,202
Food & beverage: $3,023Education: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $677 |
| Arcutis Biotherapeutics, Inc. | 18 | $385 |
| Galderma Laboratories, L.P. | 17 | $377 |
| ABBVIE INC. | 13 | $286 |
| GENZYME CORPORATION | 8 | $232 |
| PFIZER INC. | 19 | $207 |
| UCB, Inc. | 7 | $201 |
| Verrica Pharmaceuticals Inc. | 3 | $161 |
| Organon LLC | 6 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
Products named: TREMFYA, Zoryve, NEMLUVIO, DUPIXENT, SKYRIZI, Bimzelx, YCANTH, LITFULO.
Industry payments across FL — which companies pay providers there.
